Zainab R. Abdelrahman

Zainab R. Abdelrahman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zainab R. Abdelrahman has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Astragalus membranaceus Has Potential Anti-Aging and Anticancer Effects on Skin and Bone

    by Zainab R. Abdelrahman, Amani A. Harb, Shtaywy S. Abdalla

    Astragalus membranaceus, a medicinal plant used in traditional Chinese medicine for centuries, has attracted growing scientific attention for its potential anti-aging and anticancer properties, particularly for skin and bone health. Its key bioactive compounds like astragalosides, cycloastragenol, and its commercial derivative TA-65, have been associated with telomerase activation and telomere maintenance, suggesting a possible role in modulating cellular senescence and tissue repair processes. In addition to the claimed telomere maintenance, A. membranaceus exhibits antioxidant, anti-inflammatory, and DNA-protective activities, properties that contribute to its anti-aging effects. Emerging evidence also suggests that telomerase modulation by A. membranaceus influences cancer cell dynamics, either suppressing tumor progression through immune regulation and apoptosis induction or, in some contexts, potentially promoting tumor growth. This duality highlights the importance of dose, formulation, and targeted application. Clinically, TA-65 has been reported to improve vascular health, bone mineral density, and skin elasticity in aging individuals. Preclinical studies further support its protective effects against osteoporotic bone loss and photoaging-induced dermal degeneration. This review summarizes the phytochemical composition of A. membranaceus and critically evaluates the mechanistic and therapeutic evidence underlying its anti-aging and anticancer actions on skin and bone tissues. It also discusses the pharmacokinetic properties of A. membranaceus, including its absorption, bioavailability, and safety profile. The integration of A. membranaceus into evidence-based senile therapeutic strategies holds promise, but further mechanistic and clinical studies are required to optimize its safety and efficacy.

  • Open Access

    The Potential of Members of the Apple Sub‐Family Maloideae Against Obesity and Metabolic Disorders: A Review

    by Zainab R. Abdelrahman, Mai S. Maaliah, Shtaywy S. Abdalla

    Metabolic disorder, and obesity in particular, is a global epidemic among the world's population and is a complex multifactorial health problem. Obesity is associated with serious health risks like diabetes, coronary heart disease, non‐alcoholic fatty liver disease, hyperlipidemia, and hyperglycemia disorders and has shown a steady increase in morbimortality indicators. Many drugs have been approved for effective treatment of metabolic disorders and their symptoms, but the cost on the health system and on the individual patient is extremely high. Therefore, an adjunctive treatment for managing obesity and metabolic disorder could be in the use of medicinal plants and functional foods, which could reduce the cost as well as reduce the side effects of these medications. Traditional herbal medicines and functional foods have become the subject of global importance, with both medical and economic implications. The apple subfamily Maloideae includes commercially and medicinally valuable fruits like apples, pears, loquat, quince, and hawthorn, and many other plants. This subfamily has a distinctive fruit, the pome, with characteristic antioxidant content. This review summarizes the recently published research, preclinical data, brief phytochemistry, and pharmacology on 5 Maloideae genera to underscore their potential as adjunctive therapy against obesity and metabolic disorder and future research opportunities.


  • Open Access

    Ethanol Extracts of Eriobotrya japonica (Loquat) Seeds, Leaves, and Fruits Have Anti-obesity and Hypolipidemic Effects in Rats

    by Zainab R. Abdelrahman, Yasser K. Bustanji, Shtaywy S. Abdalla

    Background: Obesity is a serious public health problem contributing to development of several diseases, including hyperlipidemia, hyperglycemia, and hypertension. The plant Eriobotrya japonica (loquat) has been used in traditional Chinese medicine to treat many ailments and traditional healers used it to reduce weight. Objectives: To examine the potential anti-obesity and hypolipidemic effects of ethanol extract of loquat in rats. Materials and Methods: Loquat leaves, fruits, or seeds were extracted with ethanol. About 96 Wistar male rats were fed either a normal rat diet (normal control group; group 1) or a high-fat diet (HFD) for 12 weeks (obese; groups 2−12). Obese rats were divided into11 groups as follows: (obese control: group 2) (obese positive control which received the hypolipidemic reference drug atorvastatin: group 3). Groups (4−6), (7−9), and (10−12) were given seed, leaf, or fruit extract, respectively, at 40,100, and 400 mg/kg. Body weight, serum glucose, lipid profile, creatinine, liver enzymes, albumin, and total protein were measured weekly. Results: HFD consumption significantly increased body weight and serum total cholesterol (TC), triglycerides (TGs), low-density lipoprotein (LDL), very-low density lipoprotein (VLDL), and glucose and decreased HDL compared to rats fed the normal diet. HFD also increased serum glutamic-oxaloacetic transaminase (GOT), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP) and creatinine but decreased serum albumin and total protein. Administration of E. japonica seed, leaf, or fruit extract significantly decreased body weight, TC, TGs, LDL, VLDL, glucose, liver, and renal enzymes but increased HDL, albumin, and total protein levels. Conclusion: E. japonica seed, leaf, and fruit ethanol extract regulates body weight gain, has hypolipidemic properties, and positively affects liver and kidney enzymes.